A detailed history of Lion Street Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Lion Street Advisors, LLC holds 448 shares of LLY stock, worth $356,460. This represents 0.14% of its overall portfolio holdings.

Number of Shares
448
Previous 438 2.28%
Holding current value
$356,460
Previous $396,000 -0.0%
% of portfolio
0.14%
Previous 0.15%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$772.14 - $960.02 $7,721 - $9,600
10 Added 2.28%
448 $396,000
Q2 2024

Jul 12, 2024

SELL
$724.87 - $909.04 $5,798 - $7,272
-8 Reduced 1.79%
438 $396,000
Q4 2023

Jan 09, 2024

SELL
$525.19 - $619.13 $2,625 - $3,095
-5 Reduced 1.11%
446 $259,000
Q3 2023

Oct 19, 2023

BUY
$434.7 - $599.3 $196,049 - $270,284
451 New
451 $242,000
Q2 2020

Jul 20, 2020

SELL
$136.42 - $164.18 $12,550 - $15,104
-92 Closed
0 $0
Q1 2020

May 06, 2020

BUY
$119.05 - $147.35 $10,952 - $13,556
92 New
92 $13,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Lion Street Advisors, LLC Portfolio

Follow Lion Street Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lion Street Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lion Street Advisors, LLC with notifications on news.